Stephen L. Gwaltney
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Peptidase Inhibition and Analysis, Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Occupational and environmental lung diseases
Most-Cited Works
- → Discovery of Alogliptin: A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV(2007)401 cited
- → Vinyl Sulfonate Esters and Vinyl Sulfonamides: Potent, Irreversible Inhibitors of Cysteine Proteases(1998)226 cited
- → Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin(2017)186 cited
- → Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense(2001)179 cited
- → Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV(2010)124 cited
- → Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent(2002)123 cited
- → Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation(2003)73 cited
- → New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models(2001)66 cited
- → Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors(2008)59 cited
- → Bridged to Fused Ring Interchange. Methodology for the Construction of Fused Cycloheptanes and Cyclooctanes. Total Syntheses of Ledol, Ledene, and Compressanolide(1996)53 cited